These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 19307502)

  • 1. Overcoming resistance to conventional drugs in Ewing sarcoma and identification of molecular predictors of outcome.
    Scotlandi K; Remondini D; Castellani G; Manara MC; Nardi F; Cantiani L; Francesconi M; Mercuri M; Caccuri AM; Serra M; Knuutila S; Picci P
    J Clin Oncol; 2009 May; 27(13):2209-16. PubMed ID: 19307502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GSTM4 is a microsatellite-containing EWS/FLI target involved in Ewing's sarcoma oncogenesis and therapeutic resistance.
    Luo W; Gangwal K; Sankar S; Boucher KM; Thomas D; Lessnick SL
    Oncogene; 2009 Nov; 28(46):4126-32. PubMed ID: 19718047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overcoming glutathione S-transferase P1-related cisplatin resistance in osteosarcoma.
    Pasello M; Michelacci F; Scionti I; Hattinger CM; Zuntini M; Caccuri AM; Scotlandi K; Picci P; Serra M
    Cancer Res; 2008 Aug; 68(16):6661-8. PubMed ID: 18701490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microarray analysis of Ewing's sarcoma family of tumours reveals characteristic gene expression signatures associated with metastasis and resistance to chemotherapy.
    Schaefer KL; Eisenacher M; Braun Y; Brachwitz K; Wai DH; Dirksen U; Lanvers-Kaminsky C; Juergens H; Herrero D; Stegmaier S; Koscielniak E; Eggert A; Nathrath M; Gosheger G; Schneider DT; Bury C; Diallo-Danebrock R; Ottaviano L; Gabbert HE; Poremba C
    Eur J Cancer; 2008 Mar; 44(5):699-709. PubMed ID: 18294840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Favorable outcome of Ewing sarcoma family tumors to multiagent intensive preoperative chemotherapy: a single institution experience.
    Moschovi M; Trimis G; Stefanaki K; Anastasopoulos J; Syriopoulou V; Koultouki E; Tzortzatou-Stathopoulou F
    J Surg Oncol; 2005 Mar; 89(4):239-43. PubMed ID: 15726621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholecystokinin down-regulation by RNA interference impairs Ewing tumor growth.
    Carrillo J; García-Aragoncillo E; Azorín D; Agra N; Sastre A; González-Mediero I; García-Miguel P; Pestaña A; Gallego S; Segura D; Alonso J
    Clin Cancer Res; 2007 Apr; 13(8):2429-40. PubMed ID: 17438102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current treatment for Ewing's sarcoma.
    Thacker MM; Temple HT; Scully SP
    Expert Rev Anticancer Ther; 2005 Apr; 5(2):319-31. PubMed ID: 15877528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DAX1, a direct target of EWS/FLI1 oncoprotein, is a principal regulator of cell-cycle progression in Ewing's tumor cells.
    García-Aragoncillo E; Carrillo J; Lalli E; Agra N; Gómez-López G; Pestaña A; Alonso J
    Oncogene; 2008 Oct; 27(46):6034-43. PubMed ID: 18591936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors in non-metastatic Ewing's sarcoma tumor of bone: an analysis of 579 patients treated at a single institution with adjuvant or neoadjuvant chemotherapy between 1972 and 1998.
    Bacci G; Longhi A; Ferrari S; Mercuri M; Versari M; Bertoni F
    Acta Oncol; 2006; 45(4):469-75. PubMed ID: 16760184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo efficacy of 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol (NBDHEX) on human melanoma.
    Pellizzari Tregno F; Sau A; Pezzola S; Geroni C; Lapenta C; Spada M; Filomeni G; Bonanno E; Federici G; Caccuri AM
    Eur J Cancer; 2009 Sep; 45(14):2606-17. PubMed ID: 19665369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis and treatment of Ewing's sarcoma.
    Iwamoto Y
    Jpn J Clin Oncol; 2007 Feb; 37(2):79-89. PubMed ID: 17272319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-induced caspase-3 activation in a Ewing tumor cell line and primary Ewing tumor cells.
    Mauz-Körholz C; Kachel M; Harms-Schirra B; Klein-Vehne A; Tunn PU; Körholz D
    Anticancer Res; 2004; 24(1):145-9. PubMed ID: 15015589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of new potential anticancer drugs designed to overcome glutathione transferase mediated resistance.
    Johansson K; Ito M; Schophuizen CM; Mathew Thengumtharayil S; Heuser VD; Zhang J; Shimoji M; Vahter M; Ang WH; Dyson PJ; Shibata A; Shuto S; Ito Y; Abe H; Morgenstern R
    Mol Pharm; 2011 Oct; 8(5):1698-708. PubMed ID: 21851097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of cellular FLICE inhibitory protein, caspase-8, and protease inhibitor-9 in Ewing sarcoma and implications for susceptibility to cytotoxic pathways.
    de Hooge AS; Berghuis D; Santos SJ; Mooiman E; Romeo S; Kummer JA; Egeler RM; van Tol MJ; Melief CJ; Hogendoorn PC; Lankester AC
    Clin Cancer Res; 2007 Jan; 13(1):206-14. PubMed ID: 17200356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal stem cell features of Ewing tumors.
    Tirode F; Laud-Duval K; Prieur A; Delorme B; Charbord P; Delattre O
    Cancer Cell; 2007 May; 11(5):421-9. PubMed ID: 17482132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Ewing sarcoma family of tumors: current status and outlook for the future.
    Rodriguez-Galindo C; Spunt SL; Pappo AS
    Med Pediatr Oncol; 2003 May; 40(5):276-87. PubMed ID: 12652615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Preoperative adjuvant therapy for primary malignant bone tumors].
    Goto T; Okuma T; Nakada I; Hozumi T; Kondo T
    Gan To Kagaku Ryoho; 2007 Nov; 34(11):1750-4. PubMed ID: 18030009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural basis for the binding of the anticancer compound 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol to human glutathione s-transferases.
    Federici L; Lo Sterzo C; Pezzola S; Di Matteo A; Scaloni F; Federici G; Caccuri AM
    Cancer Res; 2009 Oct; 69(20):8025-34. PubMed ID: 19808963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ewing sarcoma].
    Hamanoue S; Makimoto A
    Gan To Kagaku Ryoho; 2007 Feb; 34(2):175-80. PubMed ID: 17301523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extraosseous localized ewing tumors: improved outcome with anthracyclines--the French society of pediatric oncology and international society of pediatric oncology.
    Castex MP; Rubie H; Stevens MC; Escribano CC; de Gauzy JS; Gomez-Brouchet A; Rey A; Delattre O; Oberlin O
    J Clin Oncol; 2007 Apr; 25(10):1176-82. PubMed ID: 17401006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.